Author

Aart Mookhoek 1

1 Amsterdam UMC,Amsterdam,Netherlands

AN EXPERT CONSENSUS TO STANDARDIZE THE ASSESSMENT OF HISTOLOGIC DISEASE ACTIVITY IN CROHN'S DISEASE CLINICAL TRIALS

Ahmed Almradi, Christopher Ma, Geert R. D'Haens, William Sandborn, Claire Parker, Leonardo Guizzetti, Paula Borralho Nunes, Geert De Hertogh, Roger M. Feakins, Reena Khanna, Gregory Y. Lauwers, Aart Mookhoek, Reet Pai, Laurent Peyrin-Biroulet, Robert Riddell, Christophe Rosty, David F. Schaeffer, Mark Valasek, Brian G. Fe

IMPACT OF 8 WEEKS TOFACITINIB TREATMENT ON HISTOLOGICAL INFLAMMATION IN PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS

Sara van Gennep, Leonie De Vries, Wouter J. de Jonge, Krisztina Barbara Gecse, Marjolijn Duijvestein, Cyriel Y. Ponsioen, Mark Lowenberg, Aart Mookhoek, Geert R. D'Haens

INCREASED RATE OF COLORECTAL CANCER IN PATIENTS WITH ULCERATIVE COLITIS: A NATIONAL COHORT STUDY BETWEEN 1991-2020

Lianne Heuthorst, Aart Mookhoek, Houda Harbech

NATURAL HISTORY OF RECURRENT CROHN'S DISEASE FOLLOWING ILEOCOLONIC RESECTION: A MULTICENTER RETROSPECTIVE CROSS-SECTIONAL COHORT STUDY

Vincent Joustra, Marjolijn Duijvestein, Aart Mookhoek, Willem A. Bemelman, Christianne Johanna Buskens, Matic Koželj, Gregor Novak, Elien Glorieus, Pieter Hindryckx, Nahid Mostafavi, Geert R. D'Haens

Item 1 - 4 / 4
1